Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the…
Tag: novo nordisk
FTC targets ‘junk’ patent listings on Ozempic and other drugs
The crackdown is the latest assault against what the agency regards as drugmakers’ patent ploys intended to stall generic competition. At issue is what is called the Orange Book, a document published…